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PSY62 Novartis Finland Oy, Espoo, NA, Finland
PSY63 Health Care Foundation ‘Spaarneland’, Leiden, NA, The 
Netherlands
PSY64 Pfi zer, spol. s r. o., Prague 5, NA, Czech Republic
PSY65 Janssen-Cilag Oy, Espoo, NA, Finland
PSY66 AbbVie Brazil, São Paulo, NA, Brazil
PSY67 Mundipharma International Ltd, Cambridge, NA, UK
PSY68 AbbVie Inc, North Chicago, IL, USA




PSY71 Roche Hellas, Athens, NA, Greece
PSY72 Covidien (UK) Commercial Ltd, now part of Medtronic, Whiteley, 
NA, UK
PSY73 None
PSY74 Bayer Healthcare, Milan, NA, Italy
PSY75 Bristol-Myers Squibb Services Sp. z o.o., Warsaw, NA, Poland
PSY76 Nestle, Lausanne, NA, Switzerland
PSY77 Amgen Europe GmBH, Zug, NA, Switzerland
PSY78 Vertex Pharmaceuticals, Boston, MA, USA
PSY79 None
PSY8 Ministry of Higher Education, Riyadh, NA, Saudi Arabia
PSY80 Genzyme, Cambridge, MA, USA
PSY81 None
PSY82 AbbVie Deutschland GmbH & Co. KG, Wiesbaden, NA, Germany
PSY83 None




PSY84 Novo Nordisk A/S, Søborg, NA, Denmark
PSY85 Grunenthal Sweden AB, Solna, NA, Sweden
PSY86 None
PSY87 None
PSY88 NOVO Nordisk, Plainsboro, NJ, USA
PSY89 Mundipharma International, Cambridge, NA, UK
PSY9 Biogen, Cambridge, MA, USA
PSY90 Novo Nordisk A/S, Søborg, NA, Denmark
PSY91 Novo Nordisk, Søborg, NA, Denmark
PSY92 Eli Lilly and Company, Indianapolis, IN, USA
PSY93 None
PSY94 Eli Lilly Japan K.K., Kobe, NA, Japan
PSY95 Swedish Board of Health and Welfare, Stockholm, NA, Sweden; 
Swedish Association of Local Authorities and Regions, Stockholm, 
NA, Sweden; Västerbotten County Council, Umeå, NA, Sweden
PSY96 None
PSY97 None
PSY98 Amgen GmbH, Munich, NA, Germany
PSY99 Novo Nordisk A/S, Søborg, NA, Denmark
PUK1 None
PUK10 Astellas, Moscow, NA, Russia
PUK11 None
PUK12 GE Healthcare, Vélizy-Villacoublay, NA, France
PUK13 Astellas Pharma, Madrid, NA, Spain
PUK14 Merck & Co., Inc., Kenilworth, NJ, USA
PUK15 None
PUK16 Astellas Pharma, Madrid, NA, Spain




PUK20 Ferring Pharmaceuticals A/S, Copenhagen, NA, Denmark
PUK21 Ferring Pharmaceuticals A/S, Copenhagen, NA, Denmark
PUK22 Ferring Pharmaceuticals A/S, Copenhagen, NA, Denmark








PUK27 Ferring, Copenhagen, NA, Denmark
PUK28 None
PUK29 Novartis Pharma, Basel, NA, Switzerland
PUK3 Bayer Pharma AG, Berlin, NA, Germany
PUK30 None
PUK31 Merck Sharp & Dohme Co., Whitehouse Station, NJ, USA
PUK32 Otsuka Pharma Scandinavia AB, Stockholm, NA, Sweden
PUK33 None
PUK34 Astellas Pharma, Stockholm, NA, Sweden
PUK35 None
PUK4 Roche, Boulogne Billancourt, NA, France; Roche, Boulogne-
Billancourt, NA, France
PUK5 None
PUK6 NIPER, S.A.S. Nagar (Mohali), NA, India
PUK7 None
PUK8 Otsuka Pharmaceutical, Madrid, NA, Spain
PUK9 None
RM1 Novartis AG, Wayne, PA, USA; GlaxoSmithKline, Philadelphia, PA, 
USA
RM2 Amgen (Europe) GmBH, Zug, NA, Switzerland
RM3 Bristol-Myers Squibb, Princeton, NJ, USA
RM4 Pfi zer Canada Inc., Kirkland, QC, Canada
RM5 None
RM6 None
RM7 National Institute for Health Research (NIHR), London, NA, UK
RM8 None
VA1 GlaxoSmithKline Biologicals SA, Rixensart, NA, Belgium
VA2 GlaxoSmithKline GmbH & Co., Munich, NA, Germany
VA3 None
VA4 GlaxoSmithKline Biologicals S.A., Rixensart, NA, Belgium
